The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions - Afshar-Oromieh, A; Hetzheim, H; Kratochwil, C (J Nucl Med, 2015)
et al.